Number of the records: 1  

Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis

  1. 1.
    0562613 - BFÚ 2023 RIV US eng J - Journal Article
    Muresan, Ximena Maria - Slabáková, Eva - Procházková, Jiřina - Drápela, Stanislav - Fedr, Radek - Pícková, Markéta - Vacek, Antonín - Víchová, Ráchel - Suchánková, Tereza - Bouchal, J. - Kurfurstova, D. - Král, M. - Hulinova, T. - Sykora, R. - Študent, V. - Hejret, V. - van Weerden, W. - Puhr, M. - Pustka, V. - Potěšil, D. - Zdráhal, Z. - Culig, Z. - Souček, Karel
    Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.
    American Journal of Pathology. Roč. 192, č. 9 (2022), s. 1321-1335. ISSN 0002-9440. E-ISSN 1525-2191
    Institutional support: RVO:68081707
    Keywords : DOCETAXEL RESISTANCE * EPITHELIAL-CELLS * TUMOR-GROWTH
    OECD category: Pathology
    Impact factor: 6, year: 2022
    Method of publishing: Limited access
    https://doi.org/10.1016/j.ajpath.2022.05.009

    Toll-like receptor 3 (TLR3) is an endosomal receptor expressed in several immune and epithelial cells. Recent studies have highlighted its expression also in solid tumors, including prostate cancer (PCa), and have described its role primarily in the proinflammatory response and induction of apoptosis. It is up-regulated in some castration-resistant prostate cancers. However, the role of TLR3 in prostate cancer progression remains largely unknown. The current study experimentally demonstrated that exogenous TLR3 activation in PCa cell lines leads to a significant induction of secretion of the cytokines IL-6, IL-8, and interferonb, depending on the model and chemoresistance status. Transcriptomic analysis of TLR3-overexpressing cells revealed a functional program that is enriched for genes involved in the regulation of cell motility, migration, and tumor invasiveness. Increased motility, migration, and invasion in TLR3-overexpressing cell line were confirmed by several in vitro assays and using an orthotopic prostate xenograft model in vivo. Furthermore, TLR3-ligand induced apoptosis via cleavage of caspase-3/7 and poly (ADP-ribose) polymerase, predominantly in TLR3-overexpressing cells. These results indicate that TLR3 may be involved in prostate cancer progression and metastasis, however, it might also represent an Achilles heel of PCa, which can be exploited for targeted therapy. (Am J Pathol 2022, 192: 1321e1335, https://doi.org/10.1016/j.ajpath.2022.05.009)
    Permanent Link: https://hdl.handle.net/11104/0340613

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.